U.S. Food Stock News

NYSE:BE
NYSE:BEElectrical

Bloom Energy’s Valuation After AI Power Demand Surge And New CFO Appointment

Bloom Energy (BE) is drawing fresh attention as data centers racing to support artificial intelligence seek dependable onsite power, putting its solid oxide fuel cells and sizable order backlog in focus for investors. See our latest analysis for Bloom Energy. Despite recent enthusiasm around AI driven power demand and Bloom’s upcoming CERAWeek appearance, momentum has cooled in the short term, with a 7 day share price return of negative 19.9% but a 1 year total shareholder return above 7x...
NYSE:WMS
NYSE:WMSBuilding

Is It Time To Reassess Advanced Drainage Systems (WMS) After The Recent Share Price Pullback

This article examines whether Advanced Drainage Systems is currently priced attractively or already reflects high expectations, by considering what the current share price might be implying about the business. The stock most recently closed at US$134.32, with returns of 21.4% over 1 year and 62.8% over 3 years, alongside a 21.4% decline over the past month and a 10.2% decline year to date. Recent coverage has discussed Advanced Drainage Systems within broader conversations about US...
NasdaqCM:WYFI
NasdaqCM:WYFIIT

WhiteFiber (WYFI) Q3 Loss Of US$15.8 Million Tests Bullish Profitability Narrative

WhiteFiber (NasdaqCM:WYFI) has posted its FY 2025 results with Q3 revenue of about US$20.2 million and a basic EPS loss of US$0.47, set against trailing twelve month revenue of roughly US$70.2 million and a net loss of US$24.2 million. Over the past several quarters, the company has seen revenue move from US$12.3 million in Q3 FY 2024 to US$20.2 million in Q3 FY 2025, while quarterly net income has swung between a profit of US$1.4 million in Q1 FY 2025 and a loss of US$15.8 million in Q3 FY...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

A Look At Lucid Group (LCID) Valuation As It Signs First European Retail Partner In Germany

Lucid Group (LCID) has signed Wackenhut as its first European retail partner in Germany, shifting to a hybrid retail model that complements its existing direct-to-consumer approach and broadens sales and service coverage. See our latest analysis for Lucid Group. Lucid’s latest European retail partnership comes after a mixed run in the market, with a 1-day share price return of 7.21% decline and a 90-day share price return of 13.15% decline, while the 1-year total shareholder return of 59.05%...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Recent Mixed Share Performance

Recent share performance and business context ACADIA Pharmaceuticals (ACAD) has seen mixed share performance recently, with a 2.5% decline over the past day, a 3.6% gain over the past week, and weaker moves over the past month and past 3 months. At a last close of US$21.47 and a market value of about US$3.8b, the company generates US$1,071.5m in revenue and US$391.0m in net income from its neurology focused medicines and pipeline programs. See our latest analysis for ACADIA...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

A Look At Euronet Worldwide (EEFT) Valuation As Shares Show Mixed Recent Performance

Euronet Worldwide (EEFT) has been drawing attention after recent share price moves, with the stock showing mixed returns over the past month and past 3 months, and a deeper pullback over the past year. See our latest analysis for Euronet Worldwide. Short term, the 1 day and 7 day share price returns suggest some momentum is returning. However, the 1 year total shareholder return of 37.73% and 5 year total shareholder return of 51.67% present a much weaker longer term picture. If Euronet...
NasdaqGS:MGTX
NasdaqGS:MGTXBiotechs

MeiraGTx Holdings (MGTX) Q3 Loss Of US$50.5m Reinforces Bearish Community Narratives

MeiraGTx Holdings (MGTX) just posted its FY 2025 third quarter numbers, with revenue at US$0.4 million and a basic EPS loss of US$0.62, alongside net income excluding extra items of a US$50.5 million loss. Over recent quarters, the company has seen revenue move from US$21.4 million in Q4 2024 to US$3.7 million in Q2 2025, while quarterly basic EPS has tracked between a loss of US$0.48 and US$0.76. This sets the backdrop for the current trailing twelve month loss of US$168.7 million on US$27.4...
NYSE:SE
NYSE:SEMultiline Retail

Is It Time To Reevaluate Sea (SE) After Sharp Multi Year Share Price Declines

If you are wondering whether Sea's current share price reflects its true worth, the recent performance gives plenty to think about before making any decisions. The stock last closed at US$79.86, with returns of a 1.4% decline over 7 days, a 25.4% decline over 30 days, and a 39.3% decline year to date, adding to a 40.2% decline over 1 year and a 66.2% decline over 5 years. These moves come as Sea remains a focal name in e commerce and digital services, where investor sentiment can shift...
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

Is It Time To Reconsider Five9 (FIVN) After Its Steep Multi‑Year Share Price Slide

If you are wondering whether Five9's current share price still reflects its potential, the recent valuation picture gives you clear numbers to work with. The stock closed at US$15.12, with returns of a 4.3% decline over 7 days, a 15.2% decline over 30 days, a 19.6% decline year to date, a 48.4% decline over 1 year, a 77.9% decline over 3 years, and a 90.8% decline over 5 years, which may change how you think about its risk and return profile. Recent coverage has focused on how Five9 fits...
NasdaqCM:HIT
NasdaqCM:HITInsurance

Health In Tech (HIT) Margin Compression Tests Bullish Narratives Despite 55.1% Revenue Growth

Health In Tech (HIT) has put up another busy quarter in FY 2025, with Q3 revenue of about US$8.5 million and basic EPS of US$0.008, set against a year where revenue was 55.1% higher and trailing net profit margins sat at 4.7% compared with 9.2% a year earlier. Over recent periods the company has seen quarterly revenue move from about US$5.0 million in Q2 2024 to US$4.9 million in Q4 2024, then to US$8.0 million in Q1 2025, US$9.3 million in Q2 2025 and US$8.5 million in Q3 2025. Over the same...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Glaukos (GKOS) Is Up 5.5% After Launching Incision-Free Epioxa Therapy For Keratoconus - What's Changed

In March 2026, Glaukos Corporation announced the commercial launch of Epioxa, an incision-free, oxygen- and light-activated corneal cross-linking therapy for keratoconus, now available directly and via specialty distributors. By pairing this new therapy with expanded patient awareness, financial assistance, and access programs, Glaukos is aiming to tackle the long-standing underdiagnosis and undertreatment of this rare corneal disease. We’ll now examine how Epioxa’s incision-free keratoconus...
NYSE:XPRO
NYSE:XPROEnergy Services

Is Expro (XPRO) Using EU Geothermal Contracts To Redefine Its Lower-Carbon Energy Positioning?

Expro announced it has delivered well testing services, including its GeoFlow™ Surface Well Testing package, for Vulcan Energy’s first Schleidberg well in the Lionheart geothermal and lithium project, working alongside VERCANA GmbH. This work embeds Expro in one of Europe’s most significant geothermal and lithium developments under the EU Critical Raw Materials Act, highlighting its long-standing geothermal expertise and emerging role in lower-carbon energy supply chains. We’ll now explore...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Did Baird’s Fresh Pick Call and Carolinas Push Just Shift Huntington Bancshares' (HBAN) Investment Narrative?

Earlier in March 2026, Baird named Huntington Bancshares a “Fresh Pick” while the bank continued expanding its branch network in the Carolinas, including a new flagship location in Winston-Salem. Combined with expectations for single-digit profit growth in the upcoming quarter, these moves have drawn attention to Huntington’s regional growth ambitions and lending momentum. We’ll now examine how Baird’s endorsement and Huntington’s Carolinas expansion may influence the bank’s existing...
NYSE:WCN
NYSE:WCNCommercial Services

Is Waste Connections (WCN) Now Attractive After A Year Of Share Price Weakness?

If you are wondering whether Waste Connections at around US$157 per share looks attractively priced or stretched, the starting point is to understand what the current valuation is really implying. The stock has seen a 4.6% decline over the past week, a 5.0% decline over the past month, and is down 9.7% year to date and 18.3% over the past year, even though the 3 year and 5 year returns stand at 16.4% and 48.9% respectively. Recent coverage has focused on how the share price pullback sits...
NYSE:PR
NYSE:PROil and Gas

Is It Too Late To Consider Permian Resources (PR) After A 60% One Year Surge?

Investors may be wondering if Permian Resources at around US$21.46 is offering good value right now, or if the easy gains are already behind it. The stock has posted returns of 7.5% over the last week, 20.6% over the past month, 49.0% year to date and 60.2% over the past year. This puts recent performance firmly on investors' radar. Recent coverage has focused on Permian Resources as an oil and gas producer in the Permian Basin, with attention on how the company is positioning itself...
NasdaqGS:PONY
NasdaqGS:PONYSoftware

Pony AI (PONY) Q3 Loss Of US$61 Million Tests High Growth Bullish Narratives

Pony AI (PONY) just posted its FY 2025 third quarter numbers, with revenue at US$25.4 million and a basic EPS loss of US$0.16, while trailing twelve month figures show revenue of US$96.4 million and a basic EPS loss of US$1.05. Over recent quarters the company has seen revenue move from US$12.2 million in Q2 2024 to US$14.8 million in Q3 2024 and then to US$13.0 million, US$21.5 million and US$25.4 million in Q1, Q2 and Q3 2025 respectively, alongside quarterly basic EPS losses of US$0.33,...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Is It Time To Reassess FuboTV (FUBO) After The Sharp Share Price Slump

If you are wondering whether FuboTV's current share price still reflects its true worth, the recent valuation checks raise some interesting questions about how the market is pricing this stock. The share price closed at US$9.66, with returns of a 30.0% decline over 7 days, 30.6% decline over 30 days, 68.9% decline year to date, 73.3% decline over 1 year, 23.3% decline over 3 years and 96.4% decline over 5 years. This sets a very specific backdrop for any valuation discussion. Recent...
NYSE:QXO
NYSE:QXOTrade Distributors

A Look At QXO (QXO) Valuation After Recent Share Price Weakness

QXO overview and recent share performance QXO (QXO), a distributor of roofing, waterproofing and building products across the US and Canada, has seen its share price move lower recently, with a 1-month return of a 21.8% decline and a past 3-month return of a 7.4% decline. See our latest analysis for QXO. Recent weakness in QXO’s share price, including a 3.1% 7 day and 21.8% 1 month share price decline from a last close of US$19.66, contrasts with its 40.3% 1 year total shareholder return...
NasdaqGS:ZYME
NasdaqGS:ZYMEBiotechs

A Look At Zymeworks (ZYME) Valuation As New AACR ADC Data Advances Its Cancer Pipeline

Why the AACR data matters for Zymeworks stock Zymeworks (ZYME) is in focus after the American Association for Cancer Research accepted an oral presentation and six abstracts covering its antibody drug conjugate pipeline, including early clinical results for ZW191 and multiple pan RAS ADC candidates. For you as an investor, this AACR presence highlights how much of Zymeworks’ current story is tied to the progress and differentiation of its proprietary platforms in difficult to treat cancers,...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Is It Too Late To Consider Cognex (CGNX) After A 62% One-Year Rally?

Wondering if Cognex at around US$49 per share still offers value, or if the easy gains are behind it? This article walks through what the current price might imply about the company. Cognex has pulled back 1.8% over the last week and 14.8% over the last month, yet still shows a 33.6% return year to date and 61.8% over the past year, with a more modest 3.6% over three years and a 39.6% decline over five years. Recent attention has focused on Cognex as a key player in machine vision and...
OTCPK:SCTH
OTCPK:SCTHAuto Components

SecureTech Innovations (OTCPK:SCTH) Turns TTM Profit Challenging Skeptical Narratives On Durability

SecureTech Innovations (OTCPK:SCTH) has wrapped up FY 2025 with Q4 revenue of about US$4.0 million and a small net loss of roughly US$0.19 million, translating to basic EPS of US$0.0058 loss. Trailing 12 month figures show total revenue of about US$7.7 million and net income of roughly US$0.11 million, or EPS of US$0.0028. Over recent quarters, the company has seen quarterly revenue move from US$0 in early 2025 to US$3.7 million in Q3 and US$4.0 million in Q4, alongside EPS shifting between...
NasdaqCM:SMPL
NasdaqCM:SMPLFood

A Look At Simply Good Foods (SMPL) Valuation After Earnings Beat And Jefferies Upgrade

Simply Good Foods (SMPL) is back in focus after reporting quarterly revenue of US$340.2 million, flat year on year but 1.2% above forecasts, alongside an earnings beat and solid contributions from Quest and OWYN. See our latest analysis for Simply Good Foods. The market reaction has been cautious despite the earnings beat, with a 30 day share price return of a 16.5% decline and a 1 year total shareholder return of a 57.5% decline, suggesting momentum has been fading even as interest in...
NYSE:WMB
NYSE:WMBOil and Gas

Is It Too Late To Consider Williams Companies (WMB) After Its Strong Multi‑Year Rally?

Investors may be wondering if Williams Companies is still fairly priced after its strong run, or if the current share price is getting ahead of itself. The stock recently closed at US$74.06, with returns of 0.0% over 7 days, 0.8% over 30 days, 21.7% year to date and 28.7% over the last year. The 3 year return is very large and the 5 year return is also very large. Recent coverage has focused on Williams Companies as a major US energy infrastructure player, with attention on its role in...
NYSE:OWL
NYSE:OWLCapital Markets

A Look At Blue Owl Capital’s (OWL) Valuation After Mixed Returns And A High Earnings Multiple

Why Blue Owl Capital Has Been Drawing Investor Attention Blue Owl Capital (OWL) has been on many investors’ radar after a period of weak share performance, with negative returns over the past month, past 3 months, year to date, and the past year. See our latest analysis for Blue Owl Capital. At a share price of US$9.02, Blue Owl Capital’s recent 30 day share price return of 15.94% and year to date share price return of 41.08% indicate fading momentum. The 1 year total shareholder return of...